Advertisement

Picture Swiss Biotech Association LSE Swiss Biotech Days 2025 Basel 650x100px
Organisation › Details

Mablink Bioscience SAS

Mablink Bioscience is a French-based biopharmaceutical company which has developed PSARlink™, an innovative and patented hydrophilic drug-linker technology that brings dramatically improved pharmacological properties to antibody-drug conjugates. Mablink Bioscience develops its own pipeline of ADC targeting several cancers with high unmet medical needs. *

 

Period Start 2018-12-05 established
  Group Eli Lilly (Group)
Products Industry PSARlink™ drug-linkers
  Industry 2 antibody-drug conjugate (ADC)
Person Person Lafay, Jean-Guillaume (Mablink Bioscience 202104 CEO + Co-Founder)
     
Region Region Lyon
  Country France
  Street 60 avenue Rockefeller
Immeuble Adenine
  City 69008 Lyon
  Tel +33-4-8776-8028
    Address record changed: 2022-10-18
     
Basic data Employees n. a.
     
    * Document for »About Section«: Mablink Bioscience SAS. (4/27/21). "Press Release: Mablink Bioscience, the Next Generation ADC Company, Raises €4 Million from a Syndicate of Private Investors". Lyon.
     
   
Record changed: 2024-03-30

Advertisement

Picture Berlin Partner Top News Aignostics Mayo Clinic Pathology 650x200px

More documents for Eli Lilly (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Swiss Biotech Association LSE Swiss Biotech Days 2025 Basel 650x300px




» top